FDA inspectors found serious problems at a Glenmark factory in India that manufactured the recalled drugs. Another medication ...

Dozens of generic medications—including some to treat conditions like high blood pressure, allergies, and high ...

Nearly 40 life-saving medications manufactured by Glenmark Pharmaceuticals Inc. have been recalled by the U.S. Food and Drug ...

Glenmark and Biocon are recalling products in the U.S. due to manufacturing issues. Glenmark is recalling 8,160 bottles of ...

Three popular over-the-counter pain medications have been recalled by Glenmark Pharmaceuticals Inc. USA due to manufacturing ...

All of the medications were generics produced by Glenmark Pharmaceuticals Inc at its factory in India and were initially recalled on March 13. The FDA gave the recall a Class II risk level on ...

Glenmark Pharmaceuticals has voluntarily recalled 24 generic prescription drugs distributed in the U.S. following concerns about potential cross-contamination at a manufacturing facility in ...

Glenmark and Biocon, two pharmaceutical companies, are recalling certain medications in the US due to manufacturing issues. The USFDA reports Glenmark is recalling Chlorpromazine for impurity issues, ...

According to the USFDA, a Class II recall is issued when the use of or exposure to a violative product may cause temporary or ...

Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, ...

This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

Glenmark Pharmaceuticals has recalled two dozen generic medicines sold to American patients because the Indian factory that made them failed to comply with U.S. manufacturing standards and the ...